EAA outputs include scientific publications

The European Access Academy aims to publish convention outcomes and learnings in peer-reviewed manuscripts.

EAA Publications:


Julian E., Xander NSH., Boumaki K., Garcia MJ., Jahimovica E., Mosset-Keane J., Otto MH., Pavlovic M., Scroccaro G., Strammiello V., Bernardini R., Capri S., Casado-Arroyo R., Desmet T., Van Dyck W., Fricke FU., Gianfrate F., Solà-Morales O., Wasem J., Wörmann BJ., Ruof J.: Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy. JMAHP 14(1), 5. (2026). doi: https://doi.org/10.3390/jmahp14010005



Julian E., Belleman T., Garcia MJ., Rutten-van Mölken M., Doeswijk R., Giuliani R., Wörmann BJ., Widmer D., Tilleul P., Casado Arroyo R., Strammiello V., Morgan K., Guardian M., Ermisch M., Bernardini R., Gianfrate F., Capri S., Uyl-de Groot CA., Pavlovic M., Ruof J.: EU HTA: Avoiding Error and Finding the Right Balance: Insights generated by the European Access Academy. JMAHP 13(1), 6. (2025). doi: https://doi.org/10.3390/jmahp13010006


Gsteiger S., Bucher HC., Ryan J., Ruof J.:
Technology Assessment vs. Technology Appraisal - How to Strengthen the Science/Value Dichotomy with EU HTA?. JMAHP 12(4), 369-377 (2024). doi: https://doi.org/10.3390/jmahp12040028


Julian E., Solà-Morales O., Garcia MJ., Brinkhuis F., Pavlovic M., Martín Saborido C., Doeswijk R., Giuliani R., Willemsen A., Goettsch W., Wörmann BJ., Dafni U., Bucher HC., Valderrama BP., Bernardini R., Gianfrate F., Uyl.de Groot CA., Ruof J.: The Role of Medical Societies and the Relevance of Clinical Perspective in the Evolving EU HTA Process: Insights generated at the 2023 Fall Convention and Survey of the European Access Academy. JMAHP 12(3), 128-143, (2024). doi: https://doi.org/10.3390/jmahp12030011


Brinkhuis F., Julian E., van den Ham H., Gianfrate F., Strammiello V., Berntgen M., Pavlovic M., Mol P., Wasem J., van Dyck W., Cardone A.,

Dierks C., Schiel A., Bernardini R., Solà-Morales O., Ruof J., Goettsch W.: Navigating the path towards successful implementation of the EU HTA Regulation: Key takeaways from the 2023 Spring Convention of the European Access Academy. Health Res Policy Sys 22,74 (2024). doi: https://doi.org/10.1186/s12961-024-01154-2


Brinkhuis F., Ruof J., van den Ham H., Gianfrate F., Strammiello V., Berntgen M., Pavlovic M., Mol P., Wasem J., van Dyck W., Cardone A.,

Dierks C., Schiel A., Solà-Morales O., Goettsch W., Julian E.: Evaluating progress towards implementation of the European HTA Regulation: Insights generated from the European Access Academy's multi-stakeholder survey. Health Policy and Technology 13(5), 100930, (2024). doi: https://doi.org/10.1016/j.hlpt.2024.100930


Desmet T., Julian, E., Van Dyck W., Simoens S., Huys I., Giuliani R., Toumi M., Dierks C., Dierks J., Cardone A., Houÿez F., Pavlovic M., Berntgen M., Mol P., Schiel A., Goettsch W., Gianfrate F., Capri S., Ryan J., Ducournau P., Solà-Morales O., Ruof J.: An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators. JMAHP 12(1), 21-34, (2024). doi: https://doi.org/10.3390/jmahp12010004


Van Haesendonck L., Ruof J., Desmet T., Van Dyck W., Simoens S., Huys I., Giuliani R., Toumi M., Dierks C., Dierks J., Cardone A., Houÿez F., Pavlovic M., Berntgen M., Mol P., Schiel A., Goettsch W., Gianfrate F., Capri S., Ryan J., Ducournau P., Solà-Morales O., Julian E.: The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire. JMAHP 11,  1, (2023). doi: https://doi.org/10.1080/20016689.2023.2217543


Julian E., Gianfrate F., Sola-Morales O., Mol PGM., Bergmann JF., Salmonson T., Hebborn A., Grande M., Ruof J.: How can a Joint European Health Technology Assessment provide an 'Additional Benefit' over the current Standard of National Assessments?. Health Econ. Rev. 12, 30 (2022). doi: https://doi.org/10.1186/s13561-022-00379-7


Julian E., Pavlovic M., Solá-Morales O., Gianfrate F., Toumi M., Bucher H.C., Dierks C., Greiner W., Mol P., Bergmann JF., Salmonson T., Hebborn A., Grande M., Cardone A., Ruof J.: Shaping a research agenda to ensure a successful European health technology assessment: insights generated during the inaugural convention of the European Access Academy. Health Econ. Rev. 12, 54 (2022). doi: https://doi.org/10.1186/s13561-022-00402-x


Journal of Market Access & Health Policy - Topical Collection on EU HTA:


The European Access Academy (EAA) and the Market Access Society (MAS) joined forces to edit a Topical Collection in the Journal of Market Access and Health Policy focused on the EU-HTA.


The full collection can be accessed online HERE


Selected manuscripts published as part of the collection (as editorials, research papers, reviews, other) to date:


Santos Ivo R., Rodrigues T., Cuoto S., Cossito M.: The Art of Bridge-Building: A Look at the European-Level Cooperation in HTA (EU-HTA). JMAHP 13(2), 26 (2025). doi: https://doi.org/10.3390/jmahp13020026


Casali PG., Capri S.: A New Health Networking Infrastructure on Cancer Is Taking Shape in Europe: A Not-to-Miss Opportunity for the EU Regulatory System. JMAHP 13(2), 18 (2025). doi: https://doi.org/10.3390/jmahp13020018


Nisticò R.: Agenzia Italiana del Farmaco (AIFA): Developments and Strategy in a Transitioning European HTA Landscape. JMAHP 13(1), 5 (2025). doi: https://doi.org/10.3390/jmahp13010005


Julian E., Xander NSH., Boumaki K., Garcia MJ., Jahimovica E., Mosset-Keane J., Otto MH., Pavlovic M., Scroccaro G., Strammiello V., Bernardini R., Capri S., Casado-Arroyo R., Desmet T., Van Dyck W., Fricke FU., Gianfrate F., Solà-Morales O., Wasem J., Wörmann BJ., Ruof J.: Development of a Performance Measurement Framework for European Health Technology Assessment: Stakeholder-Centric Key Performance Indicators Identified in a Delphi Approach by the European Access Academy. JMAHP 14(1), 5. (2026). doi: https://doi.org/10.3390/jmahp14010005


Arcá E., Barlassina A., Eze A., Strammiello, V.: Enhancing Patient-Centered Health Technology Assessment: A Modified Delphi Panel for PICOS Scoping in Spinal Muscular Atrophy. JMAHP 13(2), 27 (2025). doi: https://doi.org/10.3390/jmahp14010006


Stange AF., Julian E.: Conformity Assessment of Medical Devices: An Overview from a Notified Body. JMAHP 14(1), 4 (2026). doi: https://doi.org/10.3390/jmahp14010004

 

Houÿez F., Delaye J.: How Patients Can Contribute to the Assessment of Health Technologies. JMAHP 13(4), 61 (2025). doi: https://doi.org/10.3390/jmahp13040061


Pickaert A-P.: Patient Involvement in Health Technology Assessments: Lessons for EU Joint Clinical Assessments. JMAHP 13(3), 38 (2025). doi: https://doi.org/10.3390/jmahp13030038


Willemsen A., Rutten-van Mölken M., al Dulaimi R., Schelleman H., Goettsch W., Timmers L.: Preparing for the EU HTA Regulation: Insights from the Dutch Perspective. JMAHP 13(3), 35 (2025). doi:  https://doi.org/10.3390/jmahp13030035


Wang T., McAuslane N.: Ensuring the Efficiency and Effectiveness of Joint Clinical Assessment in National HTA Decision-Making: Insights from the 2024 CIRS Multi-Stakeholder Workshop. JMAHP 13(1), 9 (2025). doi: https://doi.org/10.3390/jmahp13010009


Julian E., Belleman T., Garcia MJ., Rutten-van Mölken M., Doeswijk R., Giuliani R., Wörmann BJ., Widmer D., Tilleul P., Casado Arroyo R., Strammiello V., Morgan K., Guardian M., Ermisch M., Bernardini R., Gianfrate F., Capri S., Uyl-de Groot CA., Pavlovic M., Ruof J.: EU HTA: Avoiding Error and Finding the Right Balance: Insights generated by the European Access Academy. JMAHP 13(1), 6. (2025). doi: https://doi.org/10.3390/jmahp13010006


Arcá E., Barlassina A., Eze A., Strammiello, V.: Enhancing Patient Engagement in HTA: Using Consensus Research  to Overcome PICO Scoping Challenges Under the EU HTAR. JMAHP 13(2), 27 (2025). doi: https://doi.org/10.3390/jmahp13020027


Broich K., Löbker W.: Towards a Unified European View of Clinical Evidence: What ‘Health Technology Assessment Organizations’ Can Learn from Regulatory Experience. JMAHP 13(2), 19 (2025). doi: https://doi.org/10.3390/jmahp13020019


Merész G., Dankó D., Molnár MP.:Public Health Decision-Maker Perspective on Joint Clinical Assessments in Central European EU Member States. JMAHP 13(1), 10 (2025). doi: https://doi.org/10.3390/jmahp13010010


Gsteiger S., Bucher HC., Ryan J., Ruof J.: Technology Assessment vs. Technology Appraisal—How to Strengthen the Science/Value Dichotomy with EU HTA? JMAHP 12(4), 369-377 (2024). doi: https://doi.org/10.3390/jmahp12040028 - 18



Affiliated Publications:


The EAA (or EAA Faculty) was involved in the following manuscripts:


Xander NSH., Rutten-van Mölken MPMH., Bertin L., Miljkovic N., Uyl-de Groot CA.: Legal implications of joint clinical assessments under the EU HTA regulation. Health Economics, Policy and Law 2, 1-13 (2026). doi: 10.1017/S1744133126100413



Leeneman B., Blommenstein HM., Delnoij DMJ, Rutten-van Mölken MPMH.: Evaluating international collaboration on horizon scanning for pharmaceuticals: developing key performance indicators for the international horizon scanning initiative. IJTAHC 42(1), e10, 1-7 (2026). doi: https://doi.org/10.1017/S0266462325103358


Comment on Leeneman et al.: Technological and scientific advancements are rapidly changing the pharmaceutical landscape. While innovative therapies can substantially improve health outcomes, their high costs place considerable pressure on healthcare budgets. Horizon scanning allows healthcare decision-makers, payers, and providers to identify pharmaceuticals with potentially significant impact on patients, public health, and healthcare systems at an early stage, which is crucial for balancing timely access with financial sustainability.

However, despite its recognized importance, practical guidance on evaluating the performance of horizon scanning is limited. In our study, published in the International Journal of Technology Assessment in Health Care, we developed a set of key performance indicators (KPIs) for the International Horizon Scanning Initiative (IHSI), in close collaboration with representatives from IHSI member countries and its Executive Committee. We also consulted horizon scanning experts from nonmember countries to identify strategies for strengthening horizon scanning where the KPIs indicate areas for improvement.

Although developed for IHSI, the KPIs can be adapted to support other national and international horizon scanning initiatives.